ATP8B1: A prognostic prostate cancer biomarker identified via genetic analysis.
Lih-Chyang ChenShu-Pin HuangChieh-Tien ShihChia-Yang LiYei-Tsung ChenChao-Yuan HuangChia-Cheng YuVictor C LinCheng-Hsueh LeeJiun-Hung GengBo-Ying BaoPublished in: The Prostate (2023)
Our study indicates that rs7239484 is a prognostic factor for patients treated with ADT and that ATP8B1 can potentially attenuate prostate cancer progression.